inThought and inThought Labs Announce AI Initiative: Cut Down Tedious Tasks

Along with the ever-increasing amounts of data and opinion at our fingertips, decision makers in all industries struggle to find the right information and the best insights. inThought Labs, the technology division of inThought, collaborates with drug makers to develop both human intelligence and artificial intelligence solutions, with the goal of elevating daily tasks from tedious information sorting to insight generation and decision making.

Current AI-based solutions include:

We invite our partners to collaborate with us to develop new AI based solutions that reduce the tedious. Our AI experts understand the regulations and confidentiality concerns of both the pharmaceutical / biotech industries and of the AI development landscape. Our inVision platform is SOC2 compliant.

For more, please see our websites www.inthought.com/ai  and  www.inthoughtlabs.com/ai.

About inThought

inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific and medical expertise, and advanced AI analytics to navigate the complex landscape of drug development. Our multidisciplinary approach integrates clinical data, market analytics, and stakeholder perspectives. Through inThought Labs, we combine cutting-edge technology with the work of our subject matter experts to transform complex data into actionable intelligence. For more information, please visit www.inthought.com. 

Contact information
Adam Schaeffer, MBA, Chief Business Officer
301.515.8262
[email protected]

View original content:https://www.prnewswire.co.uk/news-releases/inthought-and-inthought-labs-announce-ai-initiative-cut-down-tedious-tasks-302255957.html